BioRestorative Therapies
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|
Revenue | $233 | $89 | $35 |
Gross Profit | 215 | 82 | -7 |
EBITDA | -2,238 | -2,421 | -4,066 |
EBIT | -2,286 | -2,468 | -4,109 |
Net Income | -1,091 | -4,028 | -2,223 |
Net Change In Cash | 233 | 89 | 35 |
Free Cash Flow | -1,758 | -1,900 | -2,317 |
Cash | 1,489 | 2,252 | 1,157 |
Basic Shares | 8,121 | 8,121 | 6,671 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $145 | $145 | $119 | $46 |
Gross Profit | 145 | -19 | -160 | -159 |
EBITDA | -15,055 | -15,055 | -18,853 | -26,218 |
EBIT | -15,220 | -15,220 | -18,974 | -26,423 |
Net Income | -10,417 | -10,417 | -18,015 | -29,938 |
Net Change In Cash | 145 | 145 | 119 | 46 |
Free Cash Flow | -6,601 | -6,601 | -6,310 | -3,360 |
Cash | 884 | 884 | 1,676 | 21,026 |
Basic Shares | 4,218 | 4,218 | 3,617 | 1,187 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.006 |
2024-06-30 | -$0.50 |
2024-03-31 | -$0.33 |
2023-12-31 | -$0.57 |
